首页> 外文OA文献 >Analytical Validation of a Highly Sensitive, Multiplexed Chronic Myeloid Leukemia Monitoring System Targeting BCR-ABL1 RNA

【2h】

Analytical Validation of a Highly Sensitive, Multiplexed Chronic Myeloid Leukemia Monitoring System Targeting BCR-ABL1 RNA

机译：高敏感，复用慢性骨髓白血病监测系统的分析验证靶向BCR-ABL1 RNA

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Justin T. Brown; Ion J. Beldorth; Walairat Laosinchai-Wolf; Marie E. Fahey; Keri L. Jefferson; Adam K. Ruskin; Jacquelyn J. Roth; Li Cai; Christopher D. Watt; Richard D. Press; Fei Yang; John B. Hedges; Bernard F. Andruss;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Analytical Validation of a Highly Sensitive, Multiplexed Chronic Myeloid Leukemia Monitoring System Targeting BCR-ABL1 RNA [J] . Brown Justin T., Beldorth Ion J., Laosinchai-Wolf Walairat, The Journal of molecular diagnostics: JMD . 2019,第4期

机译：高敏感，复用慢性骨髓白血病监测系统的分析验证靶向BCR-ABL1 RNA
2. Potential treatment for chronic myeloid leukemia using microRNA: in silico comparison between plants and human microRNAs in targeting BCR-ABL1 gene [J] . Mohamad Syarifah Faezah Syed, Elias Marjanu Hikmah Egyptian Journal of Medical Human Genetics . 2021,第1期

机译：使用Microrna的慢性髓性白血病的潜在治疗：在靶向BCR-ABL1基因植物和人微小植物中的硅比较中
3. BCR-ABL1 Monitoring on the International Scale Using a Clinically and Analytically Validated Multiplex Assay Directly Aligned to the WHO Primary Standards and That Unifies Reporting Formats [J] . Brown J. T., Beldorth I., Laosinchai-Wolf W., The Journal of molecular diagnostics: JMD . 2016,第6期

机译：BCR-ABL1在国际范围内的监测使用了经过临床和分析验证的多重分析，该分析直接符合WHO的主要标准，并且统一了报告格式
4. Novel Inhibitors of T315I Mutant BCR-ABL1 Tyrosine Kinase for Chronic Myeloid Leukemia Disease Through Fragment-Based Drug Design [C] . Satya Anindita, Atika Marnolia, Hersal Hermana Putra, International symposium on bioinformatics research and applications . 2018

机译：T315I突变BCR-ABL1酪氨酸激酶的新型抑制剂通过基于片段的药物设计治疗慢性粒细胞白血病
5. New strategies for targeted chronic myeloid leukemia therapy: Disrupting BCR-ABL1 dimerization and secondary leukemia-specific pathways [D] . Woessner, David W. 2013

机译：针对性慢性粒细胞白血病治疗的新策略：破坏BCR-ABL1二聚化和继发性白血病特异性途径
6. Analytical Validation of a Highly Sensitive Multiplexed Chronic Myeloid Leukemia Monitoring System Targeting BCR-ABL1 RNA [O] . Justin T. Brown, Ion J. Beldorth, Walairat Laosinchai-Wolf, -1

机译：针对BCR-ABL1 RNA的高敏感性多路复用的慢性粒细胞白血病监测系统的分析验证
7. A new highly sensitive real-time quantitative-PCR method for detection of BCR-ABL1 to monitor minimal residual disease in chronic myeloid leukemia after discontinuation of imatinib [O] . Hiroaki Kitamura, Yoko Tabe, Tomohiko Ai, 2019

机译：一种用于检测BCR-ABL1的高敏感实时定量PCR方法，以在伊马替尼停止后监测慢性骨髓白血病中最小的残留疾病
8. Systematic Reviews on Selected Pharmacogenetic Tests for Cancer Treatment: CYP2D6 for Tamoxifen in Breast Cancer, KRAS for anti-EGFR antibodies in Colorectal Cancer, and BCR-ABL1 for Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia. Technology Assessment Report [R] . Terasawa, T., Dahabreh, I., Castaldi, P. J., 2010

机译：针对癌症治疗的选定药物遗传学测试的系统评价：CYp2D6用于乳腺癌中的他莫昔芬，KRas用于结肠直肠癌中的抗EGFR抗体，以及BCR-aBL1用于慢性髓性白血病中的酪氨酸激酶抑制剂。技术评估报告

Analytical Validation of a Highly Sensitive, Multiplexed Chronic Myeloid Leukemia Monitoring System Targeting BCR-ABL1 RNA

著录项

引文网络

相似文献

相关主题

期刊订阅